Antibiotic Resistance of Helicobacter pylori: Data from Central Asia

Aizhan Seisenbekova, Alyona V. Lavrinenko, Laryushina Yelena, Ayatbek Otemis, Volnovaya Olga, Maxim Solomadin, Yekaterina A. Yukhnevich, Antonella Elisa Chesca

Journal of Clinical Medicine of Kazakhstan, 2025

Full text Open access: Gold Metadata (CSL-JSON)

DOI 10.23950/jcmk/16611

Data confidence 70 medium

How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Helicobacter pylori, also known as H. pylori, is a global health concern, especially in countries with high rates of stomach cancer. Eliminating this bacterium effectively is crucial for preventing and treating related gastrointestinal conditions. Unfortunately, antibiotic resistance makes it difficult to successfully treat H. pylori infections. This review will focus on antibiotic resistance in H. pylori populations in Central Asia, as information about this issue in this region is limited.